GSK takes billion-dollar drug fight with Gilead to top AIDS meeting
Doctors will analyse the trial results closely to assess whether GSK can indeed rewrite treatment standards by delivering a…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Cipla receives final approval for testosterone injection
Cypionate Injection is AO-rated generic therapeutic equivalent version of Pharmacia and Upjohn’s DepoTestosterone
Roche buys Foundation Medicine for $2.4 billion
The drugmaker first bought a 56 per cent stake in FMI for $1 billion in 2015
Cipla gets US FDA approval for Generic Sustiva
It is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 infection…
Zydus Cadila gets US FDA nod for erectile dysfunction drug
The drug firm will be manufactured at its facility in Moraiya, Ahmedabad
US FDA approves first product from Glenmark’s US plant
The Monroe facility is Glenmark's first manufacturing site in the US, designed to manufacture a variety of fixed dose…
DRL launches Levetiracetam in Sodium Chloride Injection
The drug was launched in single-dose infusion bags in the US market
Dr Reddy’s Laboratories (DRL) has launched Levetiracetram in…
Govt to study ways for boosting pharma export to China
The move assumes significance as China is among the world's most attractive markets for pharmaceuticals and medical products
FDD Conclave 2018 witnesses knowledge sharing sessions galore on Day 2
The two- day event covered several topics issues related to formulation development and drug delivery
Lupin in partnership with Nichi-Iko
An agreement was signed for the distribution, promotion and sale of Lupin’s recently-filed biosimilar Etanercept (YLB113) in Japan
Online information on vaccines, autism not reliable: Study
The study found that people can get misinformed advice and information from the Internet, with 10-24 per cent of the websites…
Lavender Investments buys Torrent Pharma stake worth ₹ 133 cr
The foreign investor disposed of 9.01 lakh shares, amounting to 0.53 per cent stake in the drug firm
Express Pharma hosts FDD Conclave 2018, first-of-its-kind event for FR&D leaders
Powered by Ideal Cures, the event witnessed leading scientists and R&D heads from pharma organisations and top biotech…
Express Pharma hosts the second edition of FDD Leadership Awards
Honours 21 R&D thought leaders and game changers for their significant contribution towards ushering innovation and progress…
IPM clocks Rs 123973 crores in May 2018
Cardiac therapy has moved to become the No. 1 therapy in the IPM by overtaking the anti-infective therapy
Alembic Pharma receives EIR from US FDA
The inspection was carried at the formulation facility located at Panelav, Gujarat
DRL gets US FDA approval to treat adults with opioid addiction
Launches Buprenorphine and Naloxone Sublingual Film in US market
Alembic Pharma gets US FDA nod for antibiotic capsules
The drug is used for treatment of wide variety of bacterial infections
Eli Lilly’s lupus treatment succeeds in mid-stage trial
Lupus affects multiple organs and tissues in the body, causing symptoms that range from extreme fatigue and unexplained fever to…
NPPA fixes price of 22 drug formulations
While NPPA has fixed retail prices of 20 formulations, it has also capped the ceiling prices of two formulations, a notification…